Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Beactica Therapeutics AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 8,973 Less Arrow 7,481 Less Arrow 6,944
Financial expenses 79 More Arrow 111 Less Arrow 103
Earnings before taxes -5,068 Less Arrow -9,137 Less Arrow -10,075
EBITDA -5,054 Less Arrow -8,856 Less Arrow -9,781
Total assets 33,182 Less Arrow 30,363 More Arrow 34,531
Current assets 5,512 Less Arrow 4,332 More Arrow 12,179
Current liabilities 2,436 Less Arrow 2,399 More Arrow 4,088
Equity capital 30,746 Less Arrow 27,471 More Arrow 29,451
- share capital 400 Less Arrow 363 Less Arrow 319
Employees (average) 6 More Arrow 9 Less Arrow 8

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 92.7% Less Arrow 90.5% Less Arrow 85.3%
Turnover per employee 1,496 Less Arrow 831 More Arrow 868
Profit as a percentage of turnover -56.5% Less Arrow -122.1% Less Arrow -145.1%
Return on assets (ROA) -15.0% Less Arrow -29.7% More Arrow -28.9%
Current ratio 226.3% Less Arrow 180.6% More Arrow 297.9%
Return on equity (ROE) -16.5% Less Arrow -33.3% Less Arrow -34.2%
Change turnover 1,357 Less Arrow 45 More Arrow 2,717
Change turnover % 18% Less Arrow 1% More Arrow 64%
Chg. No. of employees -3 More Arrow 1 Less Arrow 0
Chg. No. of employees % -33% More Arrow 13% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.